3 employees
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
2016
$12M
from 2 investors over 2 rounds
Linnaeus Therapeutics, Inc. raised $12M on September 17, 2019
Investors: Kairos Ventures
Linnaeus Therapeutics, Inc. raised $4.4M on September 7, 2018